Please login to the form below

Not currently logged in

Cello Health acquires Advantage Healthcare to strengthen its US presence

Biopharmaceutical insight group boosts Cello’s reach

Cello HealthHealth communications and consultancy group Cello Health has bolstered its US reach by acquiring critical analysis and biopharmaceutical insight firm Advantage Healthcare.

The deal will add to Cello Health’s growing US presence and Advantage Healthcare will provide support to global client companies, with senior team members bringing marketing and market research expertise.

Stephen Highley, chairman of Cello Health, said: “We are very pleased to welcome Advantage Healthcare to the group.

“They have achieved an excellent reputation for the services they provide, which fits perfectly with our strategy of addressing our clients’ difficult challenges with high-end advisory services.”

New York and New Jersey, US-based Advantage Healthcare was founded in 1994, focussing on commercial assessments, analog intelligence and a specific rapid response service that provides for turnarounds of half or less than typical timelines.

Debbie Glick, president and founder of Advantage Healthcare, said: “Joining Cello Health will provide a win-win combination for our global healthcare clients, offering a broad base of strategic expertise and service in pipeline and marketed products across nearly 100 disease categories.”

Article by
Gemma Jones

20th July 2017

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...